Melissa Adams: Daily

Global design firm Populous is evolving, adding real estate strategy to its services to create entire entertainment ecosystems, not just stadiums.

With a new CEO who has three FDA-approved drugs to his name, Catalio-backed Rhapsogen is poised to redefine autoimmune disease treatment. Here's why.

Wealth giant Cerity Partners expands its national footprint into Austin, merging with Austin Private Wealth in a deal signaling intensified industry consolidation.

Dnsys scores three CES 2026 Innovation Awards for its Z1 exoskeleton, merging advanced human augmentation with gaming culture for the consumer market.

A new trading course blends a data expert's system with a NYSE veteran's insight. But can it tame the high-stakes world of zero-DTE options?

UnifyDrive's new UP6 combines a NAS, AI, a touchscreen, and a UPS, creating a new device category that could end laptop dependency for creators.

Establishment Labs has submitted its innovative Motiva implants for FDA approval in reconstruction, promising a new era for post-mastectomy care.

One Times Square now offers limited-time tickets for an up-close look at the famous New Year's Eve Ball before the building's grand 2026 reopening.

With the hire of a digital leader from brands like Google and Sonos, Unlock Health aims to bring modern, user-friendly tech to the healthcare industry.

Don't get stumped by risky contractors. A tree care expert shares crucial tips on licensing, insurance, and what to ask before you hire any service.

Haier's immersive festival in KL isn't just about new gadgets. It's a strategic play for brand loyalty in Malaysia's booming smart home market.

Israeli tech firm Terrific Innovation partners with BrandCloud to bring its owned-channel video commerce platform to Japan's massive, untapped market.

DPL hires Brad Mendenhall to expand its platform as RIAs increasingly embrace commission-free insurance for holistic, fiduciary-first financial planning.

A $1.2M investment isn't just charity; it's a strategic push for 'whole-person health' aimed at fixing the Pacific Northwest's deepest care gaps.

A new AI system deters birds to prevent avian flu. But its real innovation lies in data, transforming biosecurity from a costly chore into a profitable investment.

Tenaya Therapeutics unveils promising interim data for its ARVC gene therapy, TN-401, hinting at a potential cure and igniting investor interest.

Fidelity and TIAA still lead, but strategic AI investments are fueling a surge from mid-tier players, redefining the competitive retirement landscape.

Glance is partnering with IAS to bring ad verification to 250M+ users in India and Indonesia, a strategic move to combat fraud and lure premium brands.

Tariff relief was a temporary fix. A powerful federal tax credit offers farmers a sustained way to fund the innovation they perform every day.

ThoughtSpot's new suite of BI agents signals a major shift from static reports to autonomous action. But can it overcome the hurdles of trust and adoption?